A model for routine hospital-wide HIV screening: Lessons learned and public health implications

Journal of the National Medical Association

Volumn 102, Issue 12, 2010, Pages 1165-1172

  Maxwell, Celia J ^a   Sitapati, Amy M ^b   Abdus Salaam, Sayyida S ^c   Scott, Victor ^c   Martin, Marsha ^d   Holt Brockenbrough, Maya E ^a   Retland, Nicole L ^a  

^a HOWARD UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Office of the Mayor ^*

^d Office of the Mayor   (United States)

Author keywords

HIV AIDS; Screening

Indexed keywords

ADULT; AGE; ARTICLE; CLINICAL PROTOCOL; COLOMBIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GENDER; HEALTH CARE ACCESS; HEALTH CARE PLANNING; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; IMMUNOREACTIVITY; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; POPULATION MODEL; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY CONTROL; RACE; CHI SQUARE DISTRIBUTION; HOSPITAL; MIDDLE AGED; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; UNITED STATES;

ADULT; CHI-SQUARE DISTRIBUTION; DISTRICT OF COLUMBIA; FEMALE; HIV INFECTIONS; HOSPITALS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MODELS, ORGANIZATIONAL; PUBLIC HEALTH PRACTICE;

EID: 79953011463     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)30771-9     Document Type: Article

References (33)

1. Lampe MA. HIV screening in Health Care Settings: new approaches and new paradigms. Presented at the American conference on treatment of HIV, Texas, Dallas, May 31-June 3, 2007.
2. Centers for Disease Control and Prevention. HIV Prevalence Estimates - United States, 2006. MMWR. 2008;57:1073-1076.
3. Office of Minority Health. US Department of Health and Human Services. African American Profile. Modified July 2009. Available at www.omhrc. gov/templates/browse.aspx?lvl=2&lvlID=51. Accessed September 6, 2009.
4. The 2007 HIV/AIDS Surveillance Report of the Centers for Disease Control and Prevention on Cases of HIV Infection and AIDS in the United States and Dependent Areas. Atlanta, GA: Government Printing Office; 2009. US Department of Health and Human Services publication Vol. 19.
5. The District of Columbia HIV/AIDS Epidemiology Annual Update 2008. Washington, DC; 2008. DC Dept. of Health HIV/AIDS Administration, Bureau of Surveillance and Epidemiology publication.
6. Barroso PF, Schechter M, Gupta P, et al. Effect of antiretroviral therapy on HIV shedding in semen. Ann Intern Med. 2000;133:280-284. (Pubitemid 30660300)
7. Pedraza MA, del Romero J, Roldan F, et al. Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner. J Acquir Immune Defic Syndr. 1999;21:120-125. (Pubitemid 29250075)
8. Cleary PD, Devanter NV, Rogers TF, et al. Behavior changes after notification of HIV infection. Am J Public Health. 1991;81:1586-1590.
9. Colfax GN, Buchbinder SP, Cornelisse PGA, Vittinghoff E, Mayer K, Celum C. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS. 2002;16:1529-1535. (Pubitemid 34804218)
10. Demmer C. Impact of improved treatments on perceptions about HIV and safer sex among inner-city HIV-infected men and women. J Community Health. 2002;27:63-73. (Pubitemid 38481291)
11. Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, De Cock KM. The serostatus approach to fighting the HIV epidemic: prevention strategies for infected individuals. Am J Public Health. 2001;91:1019-1024. (Pubitemid 32574820)
12. Kalichman SC. Psychological and social correlates of high-risk sexual behaviour among men and women living with HIV/AIDS. AIDS Care. 1999;11:415-427. (Pubitemid 29349204)
13. Kelly JA, Hoffman RG, Rompa D, Gray M. Protease inhibitor combination therapies and perceptions of gay men regarding AIDS severity and the need to maintain safer sex. AIDS. 1998;12:F91-F95. (Pubitemid 28302411)
14. Marks G, Burris S, Peterman TA. Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. AIDS. 1999;13:297-306. (Pubitemid 29095091)
15. Marks G, Crepaz N, Senterfitt JW, Janssen RS. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39:446-453. (Pubitemid 41003791)
16. McCusker J, Stoddard AM, Mayer KH, Zapka J, Morrison C, Saltzman SP. Effects of HIV antibody test knowledge on subsequent sexual behaviors in a cohort of homosexually active men. Am J Public Health. 1988;78:462-467. (Erratum in: Am J Public Health. 1988;78:1530).
17. Beckwith CG, Flanigan TP, del Rio C, et al. It is time to implement routine, not risk-based HIV testing. Clin Infect Dis. 2005;40:1037-1040. (Pubitemid 40418313)
18. Walensky RP, Weinstein MC, Kimmel AD, et al. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. Am J Med. 2005;118:292-300. (Pubitemid 40312641)
19. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in healthcare settings. MMWR. 2006;55(RR14):1-17.
20. Centers for Disease Control and Prevention. Supplemental testing for confirmation of reactive oral fluid rapid HIV antibody tests. MMWR Dispatch. December 16, 2005.
21. Chou R, Huffman LH, Fu R, Smits AK, Korthuis PT. Screening for HIV: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2005;143:55-73.
22. OraQuick ADVANCE Rapid HIV-1/2 Antibody Test Package Insert.
23. San Antonio-Gaddy M, Richardson-Moore A, Burstein G, Newman DR, Branson B, Birkhead G. Rapid HIV antibody testing in the New York State anonymous HIV counseling and testing program: experience from the field. J Acquir Immune Defic Syndr. 2006;43:446-450. (Pubitemid 44737103)
24. Wesolowski LG, MacKellar DA, Facente SN, et al. Post-marketing surveillance of OraQuick whole blood and oral fluid rapid HIV testing. AIDS 2006;20:1661-1666. (Pubitemid 44162409)
25. Centers for Disease Control and Prevention. Rapid HIV testing in emergency departments - three US sites, January 2005-March 2006. MMWR. 2007;56:597-601.
26. Holguín A, Guitérrez M, Portocarrero N, et al. Performance of OraQuick Advance® Rapid HIV-1/2 Antibody Test for detection of antibodies in oral fluid and serum/plasma in HIV-1+ subjects carrying different HIV-1 subtypes and recombinant variants. J Virol. 2009;45:150-152.
27. Delaney KP, Branson BM, Uniyal A, et al. Performance of an oral fluid rapid HIV-1/2 test: experience from four CDC studies. AIDS 2006;20:655-660.
28. Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States - an analysis of cost-effectiveness. N Engl J Med. 2005;352:586-595. (Pubitemid 40204671)
29. Sanders GD, Bayoumi AM, Sundaram V, et al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med. 2005;352(6):570-585. (Pubitemid 40204670)
30. Walensky RP, Weinstein MC, Smith HE, et al. Optimal allocation of testing dollars: the example of HIV counseling, testing, and referral. Med Decis Making. 2005;25:321-329. (Pubitemid 40696281)
31. Janssen RS. HIV testing: rationale for changing recommendations. Top HIV Med. 2007;15(1):6-10.
32. Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87:1773-1778. (Pubitemid 127471142)
33. Lawson E, Gardezi F, Calzavara L, Husbands W, Myers T. HIV/AIDS stigma, denial, fear, and discrimination 2006. The African and Caribbean Council on HIV/AIDS in Ontario and the HIV Social, Behavioral and Epidemiological Studies Unit, University of Toronto.